Clinical Trials Browser

INDUSTRY × Hyperuricemia × Allopurinol × Clear all

NCT02500641 2019-06-21

FORWARD

Phase 4 Completed

196 enrolled 9 charts

Arthritis, Cardiovascular Diseases, Gout, Inflammation, Hyperuricemia

NCT00607152 2014-05-08

Rasburicase (Fasturtec) Registration Trial

Phase 3 Terminated

Hyperuricemia

NCT00230178 2010-01-12

Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome

Phase 3 Completed

280 enrolled 10 charts

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Myelodysplastic Syndromes, Neoplasms, Tumor Lysis Syndrome, Hyperuricemia